Corvus Pharmaceuticals
About:
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Website: http://www.corvuspharma.com/
Top Investors: BlackRock, Fidelity, OrbiMed, Adams Street Partners, Point72
Description:
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
Total Funding Amount:
$246M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Burlingame, California, United States
Founded Date:
2014-01-01
Founders:
Joseph J Buggy, Peter Thompson, Richard A Miller
Number of Employees:
11-50
Last Funding Date:
2024-05-02
IPO Status:
Public
Industries:
© 2025 bioDAO.ai